Medical therapies for the management of cardiomyopathy and chronic congestive heart failure
- First Online:
- 36 Downloads
Medical therapy for congestive heart failure has rapidly evolved over the past decade to include a spectrum of therapies that extend well beyond the traditional pharmaceutical-based strategies of the past. These therapies include multidisciplinary care, transplantation, device-based therapies with resynchronization, defibrillator therapy, and an expanding array of circulatory support devices designed for patients with both acute and chronic heart failure. It is critical that clinicians develop an understanding of the illness trajectory associated with heart failure progression in order to choose the most appropriate management strategies for each stage of the disease.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 6.Yancy CW, Lopatin M, Stevenson LW, et al.: Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006, 47:76–84.PubMedCrossRefGoogle Scholar
- 7.Cleland JG, Swedberg K, Cohen-Solal A, et al.: The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail 2000, 2:123–132.PubMedCrossRefGoogle Scholar
- 10.Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, et al.: Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005, 149:209–216.PubMedCrossRefGoogle Scholar
- 11.Hunt SA, Baker DW, Chin MH, et al.: ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001, 104:2996–3007.PubMedCrossRefGoogle Scholar
- 12.Hunt SA, Abraham WT, Chin MH, et al.: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154–235.PubMedCrossRefGoogle Scholar
- 29.Seyfarth M, Sibbing D, Bauer I, et al.: A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008, 52:1584–1588.PubMedCrossRefGoogle Scholar
- 34.Bekelman DB, Rumsfeld JS, Havranek EP, et al.: Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med 2009 (in press).Google Scholar